- Home
- CPS vs DBVT Comparison
CPS vs DBVT Comparison
Compare CPS & DBVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CPS
- DBVT
- Stock Information
- Founded
- CPS 1960
- DBVT 2002
- Country
- CPS United States
- DBVT France
- Employees
- CPS N/A
- DBVT N/A
- Industry
- CPS Auto Parts:O.E.M.
- DBVT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CPS Consumer Discretionary
- DBVT Health Care
- Exchange
- CPS Nasdaq
- DBVT Nasdaq
- Market Cap
- CPS 462.2M
- DBVT 464.0M
- IPO Year
- CPS N/A
- DBVT N/A
- Fundamental
- Price
- CPS $37.84
- DBVT $14.12
- Analyst Decision
- CPS Buy
- DBVT Buy
- Analyst Count
- CPS 2
- DBVT 4
- Target Price
- CPS $26.50
- DBVT $14.81
- AVG Volume (30 Days)
- CPS 163.0K
- DBVT 203.8K
- Earning Date
- CPS 10-30-2025
- DBVT 10-28-2025
- Dividend Yield
- CPS N/A
- DBVT N/A
- EPS Growth
- CPS N/A
- DBVT N/A
- EPS
- CPS 1.65
- DBVT N/A
- Revenue
- CPS $2,719,148,000.00
- DBVT $3,800,000.00
- Revenue This Year
- CPS $2.31
- DBVT $1,743.46
- Revenue Next Year
- CPS $3.69
- DBVT $1,044.34
- P/E Ratio
- CPS $22.98
- DBVT N/A
- Revenue Growth
- CPS N/A
- DBVT N/A
- 52 Week Low
- CPS $10.38
- DBVT $2.21
- 52 Week High
- CPS $40.67
- DBVT $18.00
- Technical
- Relative Strength Index (RSI)
- CPS 59.66
- DBVT 50.21
- Support Level
- CPS $31.47
- DBVT $14.85
- Resistance Level
- CPS $39.00
- DBVT $16.95
- Average True Range (ATR)
- CPS 1.56
- DBVT 1.04
- MACD
- CPS 0.47
- DBVT -0.30
- Stochastic Oscillator
- CPS 85.50
- DBVT 0.00
About CPS Cooper-Standard Holdings Inc.
Cooper-Standard Holdings Inc is engaged in the manufacture of sealing and fluid handling systems (consisting of fuel and brake delivery systems and fluid transfer systems). Its products are designed for passenger vehicles and light trucks that are manufactured by automotive original equipment manufacturers (OEMs) and replacement markets. It has two reportable segments: Sealing Systems and Fluid Handling Systems. The group's geographic regions are North America, Europe, Asia Pacific, and South America.
About DBVT DBV Technologies S.A.
DBV Technologies SA is a clinical-stage specialty biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin. The therapeutic approach is based on epicutaneous immunotherapy or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin, an epicutaneous patch (i.e., a skin patch). Its main product candidate under development is Viaskin Peanut for the treatment of peanut-allergic patients. In addition, the company also has earlier-stage food allergy programs, including Viaskin Milk and Eosinophilic Esophagitis, or EoE.